Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers
Clinical trial NCT01123772 · COMPLETED
Trial details
- NCT number
- NCT01123772
- Sponsor
- Inotek Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.